Twist Bioscience Corp Stock
Price
Target price
€41.21
€41.21
-5.360%
-2.39
-5.360%
€41.01
20.02.26 / Tradegate
WKN: A2N7L2 / Symbol: TWST / Name: Twist Bioscience / Stock / Pharmaceuticals / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Twist Bioscience Corp Stock
Heavy losses for Twist Bioscience Corp today as the stock fell by -€2.390 (-5.360%).
With 13 Buy predictions and only 1 Sell predictions the community sentiment for the stock is positive.
However, we have a potential of -0.51% for Twist Bioscience Corp as the target price of 41 € is below the current price of 41.21 €.
Criterium "Revenue growth" is seen as the biggest plus for Twist Bioscience Corp stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of Twist Bioscience Corp in the next few years
Pros
?
M***** P*******
?
G***** c******* t* c**********
?
S********** s********
Cons
?
W********* I********* f** t** n*** y****
?
B****
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Twist Bioscience Corp vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Twist Bioscience Corp | -5.360% | -0.218% | 15.921% | -4.029% | 47.971% | 95.077% | -67.032% |
| Rockwell Medical Inc. | -1.740% | 0.059% | -19.516% | -50.641% | 25.277% | -63.152% | -94.250% |
| Pacira Pharmaceuticals | -4.570% | 2.732% | 13.939% | -22.314% | -12.963% | -51.042% | -69.180% |
| Vericel Corp. | 0.000% | 6.623% | 3.205% | -37.476% | 1.899% | 15.661% | -24.678% |
Comments
Twist Bioscience (NASDAQ:TWST) had its "outperform" rating reaffirmed by analysts at Evercore ISI.
Show more
Ratings data for TWST provided by MarketBeat
Twist Bioscience (NASDAQ:TWST) had its "buy" rating reaffirmed by analysts at Guggenheim.
Show more
Ratings data for TWST provided by MarketBeat
Twist Bioscience (NASDAQ:TWST) had its price target raised by analysts at TD Cowen from $32.00 to $43.00. They now have a "buy" rating on the stock.
Show more
Ratings data for TWST provided by MarketBeat